Earnings Preview: Hologic

Medical device manufacturer Holgoic

is set to release its quarterly earnings results on Monday after the closing bell. Heading into the report, Wall Street analysts have consensus earnings per share estimates for the company of $0.37. This represents earnings growth of 8.82 percent versus the year ago period. The high estimate on Wall Street is $0.39 per share with a low estimate of $0.34. Sales are expected to be $581.62 million which represents year over year growth of 24.50 percent versus the $467.04 million that Hologic reported in last year's corresponding quarter. The high revenue estimate is $590.91 million with a low estimate of $562.09 million. Over the last 3 months, earnings estimates for the company have risen by one penny from $0.36 to $0.37. During this time period, HOLX has added around 2 percent. On Friday, ahead of Monday's key report, HOLX climbed 1.25 percent to close at $20.32. The 52-week high in the stock is $22.16 and this level could come into play if the company surprises estimates to the upside on Monday.